We have discussed the influence of TREM2 on obesity, atherosclerosis and NAFLD, which are considered metabolic comorbidities of AD and disrupt the homeostasis of peripheral lipid metabolism. The gene discussed is TREM2; the disease is metabolic dysfunction-associated steatotic liver disease.